Clinical trial
A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer
NCT02068092 is registered in ClinicalTrials.gov with The Methodist Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer
- Lead sponsor
- The Methodist Hospital Research Institute
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- July 31, 2021
- Enrollment
- 51 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer